Blogs & News

Huvepharma® acquires T-HEXX® Animal Health

August 28, 2018 (Peachtree City, GA) – Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.

T-HEXX Animal Health manufacturers and sells a broad range of products utilizing patented hydrophilic polymer technologies designed for mastitis management in dairy cattle, hoof care, and unique germicidal topical products for horses. They serve customers in the U.S. and internationally.

“The purchase of T-HEXX Animal Health supports Huvepharma’s vision for growth and development,” remarked Glen Wilkinson, President of Huvepharma U.S. “T-HEXX has created great products for the dairy and equine markets and we are thrilled to add these unique product lines to our portfolio.”

“Huvepharma will immediately assume marketing and sales of T-HEXX brands to our current customers while utilizing the sales and marketing strengths of Huvepharma. This timely purchase appropriately follows the recent announcement of a new dairy cattle vaccine – KLEBVax SRP”, added Wilkinson.

About Huvepharma

Huvepharma acquired AgriLabs, a U.S. leader in biological innovation for animal health, earlier in 2018. AgriLabs' product range includes licensed and custom vaccines, proprietary DNA platform and adjuvant technologies and other leading brands.


About Hydromer, Inc.

Hydromer is an innovative, certified polymer development company engaged in the business of listening to the voices of our clients, focusing on their goals by inventing, developing, patenting, licensing, manufacturing polymer-based products and services. We serve the medical device, pharmaceutical, animal health, biotechnology, industrial, cosmetic, and personal care markets.